MergermarketAugust 2018
Apicil remains on the lookout for new acquisition opportunities in Europe, exec says
Communiqué de presseAugust 2018
Apicil acquires OneLife (€5.2bn in assets under management), a European leader in customised asset and wealth management solutions from JC Flowers pending regulatory clearance from the CAA in Luxembourg.
Communiqué de presseJuly 2018
Le consortium composé des Groupes Apicil,OFI, et Crystal est entré en discussions exclusives en vue du rachat de la plateforme FINAVEO & Associés
Etude prospective des organisations et des métiers de l\'informationMay 2018
AEC Partners accompagne le LEEM et donne une vision de l’évolution des organisations et des métiers de l’information auprès des Professionnels de santé, au sein des filiales France.
Si vous souhaitez recevoir l’étude complète, n’hésitez pas à en faire la demande via notre formulaire de contact.
Moreau SAS fait l\'acquisition de la société portugaise TEMAHOME SAJanuary 2018
MOREAU SAS fait l\'acquisition de la société portugaise TEMAHOME SA, conseillée par Stéphane Olmi - AEC Partners
La startup de la finance FundShop lève 2,2 millions d’euros auprès d’ApicilJune 2017
La startup de la finance FundShop lève 2,2 millions d’euros auprès d’Apicil, conseillée par Stéphane Olmi - AEC Fintech
Mrs Garnier appointed as Onxeo board memberApril 2017
Mrs. Christine Garnier, AEC Partners Managing Partner, was appointed as Onxeo board member
ACQUISITION INTERNATIONALApril 2017
AEC Partners was recognized as the Best French Life Sciences M&A Advisory Firm of the Year from the magazine Acquisition International
DécideursMarch 2017
AEC Partners ranked as « Excellent » among Healthcare consultants by Strategy & Finance Business magazine “Décideurs”
BiotechfinancesDecember 2016
Comment les biotech pourront-elles innover demain ?
AEC Partners salue le lancement du Lab SantéDecember 2016
AEC Partners pays tribute to the official launch of Lab Santé/
AEC Partners tient à saluer le lancement officiel du Lab Santé
Etude Biotechs/Innovations Santé 2020November 2016
AEC Partners accompagne le LEEM France et donne une vision de l’évolution des 10 grandes familles de Biotechs/Innovations Santé à 2020
Orange ConsultingApril 2015
AEC Partners and Orange Consulting are uniting their strengths and complementary expertise to address digital opportunities and challenges along the full value chain for life science companies.
APICILFebruary 2015
Groupe APICIL : feu vert pour l’acquisition des activités de Skandia en France
et au Luxembourg auprès d’Old Mutual
Acquisition of Skandia FranceSeptember 2014
Stéphane Olmi, Partner, advised Apicil Assurances on the acquisition of Skandia France, the French life-insurance subsidiary of Old Mutual
ACQUISITION INTERNATIONALJuly 2014
AEC Partners was recognized as the French Healthcare Advisory Firm of the Year 2014, by the magazine Acquisition International
ETUDE PRISME – AEC PARTNERS POUR L’AMIPSApril 2014
Projection sur la Responsabilité des Industries de Santé, leurs métiers Médicaux et leurs Evolutions Télécharger l’étude Lire un article
InvestirOctober 2013
AEC Partners in the press – Investir – Dossier « Un traitement de choc efficace pour les géants de la pharmacie » Read the article
BIOTECH FINANCESSeptember 2013
AEC Partners on the cover page of Biotech Finances «Après les USA, la biotech européenne peut-elle rebondir ?»
Sale of Laserson SASeptember 2013
Stéphane Olmi, Partner at AEC Partners, advised the Laserson family on the sale of Laserson SA to Safic-Alcan
ACQUISITION INTERNATIONALJuly 2013
AEC Partners was recognized as the French Healthcare Advisory Firm of the Year from the magazine Acquisition International. See the M&A Award
DÉCIDEURSJanuary 2013
AEC Partners ranked as « Excellent » among Healthcare consultants by Strategy & Finance Business magazine “Décideurs”
MEDCDTLL édite son avenirJuly 2012
AEC Partners assisted Edmond de Rothschild Investment Partners in assessing Edimark’s strategic outlook. Beyond Edimark’s competitive position and strengths, it was critical to provide a comprehensive understanding of where drug promotion is going in France, and in particular the consequences of complex environmental and regulatory changes on medical and scientific press. We believe that our intimate understanding of the challenges faced by the drug industry comforted Edrip in their investment decision.
Edrip and AEC Partners have been collaborating on a regular basis over the past 3 years. Rodolphe Gobe, Partner at AEC Partners, was in charge of this assignment.
BIOTECH FINANCESMay 2012
Alkantis un pure player medtech…
BIOTECH FINANCESApril 2012
Immunothérapie 2025 : quelles opportunités pour la France ?
DÉCIDEURSJanuary 2012
We are referenced in the Strategy & Finance Publication “Décideurs” in January 2012 among their “Best of” Financial Advisory companies for the Healthcare & Pharmaceutical Industry: Small & Mid Size Cap -
ETUDE POUR LE LEEM SUR L’ÉVOLUTION DES FORCES TERRAINNovember 2011
AEC PARTNERS PARTICIPATION ON THE OECD BIOMARKERS REPORTNovember 2011
BIOTECH FINANCESOctober 2011
Biosimilaires d’anticorps monoclonaux : un avenir incertain ?
AEC Partners advised IPL in selling its Food Control activity to AlpJuly 2011
AEC Partners advised Marceau Conseil in selling one of their activitiesJuly 2011
ETUDE POUR LE LEEM SUR LES MÉTIERS ÉMERGENTSJune 2011
